Skip to main content
Premium Trial:

Request an Annual Quote

Genome Pharmaceuticals Sets Up Research Team


MUNICH--Genome Pharma ceuticals, a genomics-based drug discovery company here, announced the appointment of Zoltan Nagy as vice-president of immunology. Nagy previously held positions as a scientific member of the Basel Institute of Immunology, deputy director of the Max Planck Institute for Biology, project leader in preclinical research at Novartis, and most recently as department head of immunology at Hoffmann-La Roche.

Genome Pharmaceuticals said it has an integrated platform of automated and proprietary high-throughput functional genomics technologies comprising in-depth gene structure and expression analyses, protein-protein interaction mapping, and advanced bioinformatics tools designed to streamline the process of target identification and validation. The company said its short-term goal is to assist major pharmaceutical companies in the process of drug discovery and development. The company said it also plans further to expand its technology base to become an integrated drug discovery company.

Filed under

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.